Quarterly report pursuant to Section 13 or 15(d)

Statements of Stockholders' Equity (Unaudited)

v3.21.1
Statements of Stockholders' Equity (Unaudited) - USD ($)
Common Stock
Additional Paid-In Capital
Accumulated Deficit
Total
Beginning balance, shares at Dec. 31, 2019 16,450,234      
Beginning balance, value at Dec. 31, 2019 $ 16,450 $ 19,073,098 $ (11,488,472) $ 7,601,076
Stock-based compensation, shares      
Stock-based compensation, value 242,209 242,209
Net loss (1,968,131) (1,968,131)
Ending balance, shares at Mar. 31, 2020 16,450,234      
Ending balance, value at Mar. 31, 2020 $ 16,450 19,315,307 (13,456,603) 5,875,154
Beginning balance, shares at Dec. 31, 2020 23,856,151      
Beginning balance, value at Dec. 31, 2020 $ 23,856 34,870,471 (20,946,343) 13,947,984
Common stock issued for cash, value $ 43 144,800 144,843
Exercise of warrants, shares 1,447,325      
Exercise of warrants, value $ 1,447 331,303 332,750
Stock-based compensation, shares 6,250      
Stock-based compensation, value $ 6 430,673 430,679
Net loss (3,613,404) (3,613,404)
Ending balance, shares at Mar. 31, 2021 25,352,809      
Ending balance, value at Mar. 31, 2021 $ 25,352 $ 35,777,247 $ (24,559,747) $ 11,242,852